🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The primary objective is to provide dose-ranging data for 4 dose regimens o...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2019-07-31
Trial ID
NCT04015518
Treatments Being Tested
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
Vitiligo is a long-term autoimmune condition that causes the skin to lose i...
Status
Recruiting
Location
Dermatology Trial Associates
Start Date
2025-11-03
Trial ID
NCT07108283
Treatments Being Tested
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Inves...
Status
Recruiting
Location
Laboratory for Muscle Diseases and Neuropathies
Start Date
2025-02-13
Trial ID
NCT06523400
Treatments Being Tested
Asthma is a common, chronic inflammatory disease of the bronchial airways, ...
Status
Completed
Location
HORNMED s.r.o.
Start Date
2011-10
Trial ID
NCT01436890
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
The main objectives of this trial are to investigate safety, tolerability, ...
Status
Completed
Location
Clinical Research Hospital Tokyo
Start Date
2024-04-19
Trial ID
NCT06310005
Treatments Being Tested
This clinic trial evaluates the safety and tolerability of single- and mult...
Status
Completed
Location
Zhejiang Xiaoshan Hospital
Start Date
2023-02-13
Trial ID
NCT06281470
The main objectives of this trial are to investigate safety, tolerability a...
Status
Completed
Location
SOUSEIKAI Sumida Hospital
Start Date
2023-07-13
Trial ID
NCT05934955
Treatments Being Tested